Author:
Slobodin Gleb,Rosner Itzhak,Feld Joy,Rimar Doron,Rozenbaum Michael,Boulman Nina,Odeh Majed
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Rheumatology
Reference56 articles.
1. Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A et al (2002) A six-months randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis. Arthritis Rheum 46:766–773
2. Maksymowych WP, Jhangri GS, LeClercq S, Skeith K, Yan A, Russell AS (1998) An open study of pamidronate in the treatment of refractory ankylosing spondylitis. J Rheumatol 25:714–717
3. Maksymowych WP, Lambert R, Jhangri GS, LeClercq S, Chiu P, Wong B et al (2001) Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy. J Rheumatol 28:144–155
4. Haibel H, Brandt J, Rudwaleit M, Soerensen H, Sieper J, Braun J (2003) Treatment of active ankylosing spondylitis with pamidronate. Rheumatology 42:1018–1020
5. Cairns AP, Wright SA, Taggart AJ, Coward SM, Wright GD (2005) An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover. Ann Rheum Dis 64:338–339
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献